Ananda brings in new commercial adviser
Ananda Pharma (AQSE: ANA), is a UK-based developer of licenced, CBD-based medicinal products, has appointed Andy Rust as a commercial adviser, to provide the company with expert advice on its drug development and commercialisation plans.